UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Propensity score weighting analysis and treatment effect discovery

Statistical methods in medical research, 2019-08, Vol.28 (8), p.2439-2454

2019

Volltextzugriff (PDF)

GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration

American journal of kidney diseases, 2014-12, Vol.64 (6), p.821-835

2014

Volltextzugriff (PDF)

New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race

The New England journal of medicine, 2021-11, Vol.385 (19), p.1737-1749

2021

Volltextzugriff (PDF)

APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease

The New England journal of medicine, 2013-12, Vol.369 (23), p.2183-2196

2013

Volltextzugriff (PDF)

Implementation of a Value-Driven Outcomes Program to Identify High Variability in Clinical Costs and Outcomes and Association With Reduced Cost and Improved Quality

JAMA : the journal of the American Medical Association, 2016-09, Vol.316 (10), p.1061

2016

Volltextzugriff (PDF)

Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate

The New England journal of medicine, 2006-06, Vol.354 (23), p.2473-2483

2006

Volltextzugriff (PDF)

Longitudinal Progression Trajectory of GFR Among Patients With CKD

American journal of kidney diseases, 2012-04, Vol.59 (4), p.504-512

2012

Volltextzugriff (PDF)

GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials

Journal of the American Society of Nephrology, 2019-09, Vol.30 (9), p.1735-1745

2019

Volltextzugriff (PDF)

Early Change in Proteinuria as a Surrogate End Point for Kidney Disease Progression: An Individual Patient Meta-analysis

American journal of kidney diseases, 2014-07, Vol.64 (1), p.74-85

2014

Volltextzugriff (PDF)

Light-intensity physical activities and mortality in the United States general population and CKD subpopulation

Clinical journal of the American Society of Nephrology, 2015-07, Vol.10 (7), p.1145-1153

2015

Volltextzugriff (PDF)

Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C

The New England journal of medicine, 2012-07, Vol.367 (1), p.20-29

2012

Volltextzugriff (PDF)

GFR Decline as an Alternative End Point to Kidney Failure in Clinical Trials: A Meta-analysis of Treatment Effects From 37 Randomized Trials

American journal of kidney diseases, 2014-12, Vol.64 (6), p.848-859

2014

Volltextzugriff (PDF)

Urine Ammonium Predicts Clinical Outcomes in Hypertensive Kidney Disease

Journal of the American Society of Nephrology, 2017-08, Vol.28 (8), p.2483-2490

2017

Volltextzugriff (PDF)

Randomized and Observational Studies in Nephrology: How Strong Is the Evidence?

American journal of kidney diseases, 2009-03, Vol.53 (3), p.377-388

Greene, Tom, PhD

2009

Volltextzugriff (PDF)

From Static to Dynamic Risk Prediction: Time Is Everything

American journal of kidney diseases, 2017-04, Vol.69 (4), p.492-494

2017

Volltextzugriff (PDF)

Effects of Intensive BP Control in CKD

Journal of the American Society of Nephrology, 2017-09, Vol.28 (9), p.2812-2823

2017

Volltextzugriff (PDF)

Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial

Journal of the American Society of Nephrology, 2020-05, Vol.31 (5), p.1128-1139

2020

Volltextzugriff (PDF)

A new equation to estimate glomerular filtration rate

Annals of internal medicine, 2009-05, Vol.150 (9), p.604

2009

Volltextzugriff (PDF)

The Associations of Plant Protein Intake With All-Cause Mortality in CKD

American journal of kidney diseases, 2016-03, Vol.67 (3), p.423-430

2016

Volltextzugriff (PDF)

Predicting the risk of a clinical event using longitudinal data: the generalized landmark analysis

BMC medical research methodology, 2023-01, Vol.23 (1), p.5-14, Article 5

2023

Volltextzugriff (PDF)

Long-term Effects of Frequent Nocturnal Hemodialysis on Mortality: The Frequent Hemodialysis Network (FHN) Nocturnal Trial

American journal of kidney diseases, 2015-09, Vol.66 (3), p.459-468

2015

Volltextzugriff (PDF)

Related Causal Frameworks for Surrogate Outcomes

Biometrics, 2009-06, Vol.65 (2), p.530-538

2009

Volltextzugriff (PDF)

Comparison of As-Needed and Scheduled Posthospitalization Follow-up for Children Hospitalized for Bronchiolitis: The Bronchiolitis Follow-up Intervention Trial (BeneFIT) Randomized Clinical Trial

JAMA pediatrics, 2020-09, Vol.174 (9), p.e201937

2020

Volltextzugriff (PDF)

1 – 25 von 970

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(883)
Mit Volltextzugriff
(812)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(643)
Life Sciences & Biomedicine
(599)
Humans
(548)
Female
(349)
Male
(347)
Middle Aged
(288)
Urology & Nephrology
(247)
Adult
(224)
Aged
(219)
Biological And Medical Sciences
(196)
Medical Sciences
(191)
Glomerular Filtration Rate
(132)
Nephrology. Urinary Tract Diseases
(104)
Risk Factors
(98)
General & Internal Medicine
(79)
Adolescent
(78)
Follow-Up Studies
(77)
Treatment Outcome
(75)
Disease Progression
(72)
Medicine, General & Internal
(69)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Propensity score weighting analysis and treatment effect discovery

GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration

New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race

APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease

Implementation of a Value-Driven Outcomes Program to Identify High Variability in Clinical Costs and Outcomes and Association With Reduced Cost and Improved Quality

Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate

Longitudinal Progression Trajectory of GFR Among Patients With CKD

GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials

Early Change in Proteinuria as a Surrogate End Point for Kidney Disease Progression: An Individual Patient Meta-analysis

Light-intensity physical activities and mortality in the United States general population and CKD subpopulation

Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C

GFR Decline as an Alternative End Point to Kidney Failure in Clinical Trials: A Meta-analysis of Treatment Effects From 37 Randomized Trials

Urine Ammonium Predicts Clinical Outcomes in Hypertensive Kidney Disease

Randomized and Observational Studies in Nephrology: How Strong Is the Evidence?

From Static to Dynamic Risk Prediction: Time Is Everything

Effects of Intensive BP Control in CKD

Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans

Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial

A new equation to estimate glomerular filtration rate

The Associations of Plant Protein Intake With All-Cause Mortality in CKD

Predicting the risk of a clinical event using longitudinal data: the generalized landmark analysis

Long-term Effects of Frequent Nocturnal Hemodialysis on Mortality: The Frequent Hemodialysis Network (FHN) Nocturnal Trial

Related Causal Frameworks for Surrogate Outcomes

Comparison of As-Needed and Scheduled Posthospitalization Follow-up for Children Hospitalized for Bronchiolitis: The Bronchiolitis Follow-up Intervention Trial (BeneFIT) Randomized Clinical Trial

The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics

Suchergebnisse filtern